Yuji Kitahata
Papers
1
Total Citations
9
H-Index
1
About
Dr. Yuji Kitahata is a leading surgical oncologist whose research centers on advancing minimally invasive techniques for pancreatic cancer treatment. His major contribution lies in spearheading rigorous, high-impact clinical trials that directly compare the efficacy and safety of minimally invasive distal pancreatectomy (MIDP) against traditional open surgery. As the principal investigator of the landmark, multi-institutional randomized phase III study (JCOG2202, LAPAN study), Dr. Kitahata is addressing a critical evidence gap in surgical oncology. While MIDP is known for improved short-term recovery, its oncologic safety for pancreatic cancer remained unproven. His work is pivotal in establishing whether laparoscopic and robotic approaches can match open surgery in achieving long-term cancer control. This trial, published in 2024, has already garnered significant attention with 9 citations in its early stages, reflecting its immediate impact on clinical practice. Dr. Kitahata’s research is not only shaping surgical guidelines but also directly influencing patient outcomes by defining the safest, most effective surgical strategies for pancreatic cancer. His commitment to evidence-based surgery positions him as a key figure in the global effort to improve survival and quality of life for pancreatic cancer patients.
Research Focus
Key Achievements
Top Papers
- 1